BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20073041)

  • 1. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells.
    Zhou Z; French DL; Ma G; Eisenstein S; Chen Y; Divino CM; Keller G; Chen SH; Pan PY
    Stem Cells; 2010 Mar; 28(3):620-32. PubMed ID: 20073041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.
    Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q
    Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity.
    Wu J; Zhang R; Tang N; Gong Z; Zhou J; Chen Y; Chen K; Cai W
    J Leukoc Biol; 2015 Jan; 97(1):191-200. PubMed ID: 25341727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-Versus-Host Disease Prevention by
    Scheurer J; Kitt K; Huber HJ; Fundel-Clemens K; Pflanz S; Debatin KM; Strauss G
    Front Immunol; 2021; 12():754316. PubMed ID: 34721430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
    Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-18 enhances immunosuppressive responses by promoting differentiation into monocytic myeloid-derived suppressor cells.
    Lim HX; Hong HJ; Cho D; Kim TS
    J Immunol; 2014 Dec; 193(11):5453-60. PubMed ID: 25362180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.
    Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY
    J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
    Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
    Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.
    Highfill SL; Rodriguez PC; Zhou Q; Goetz CA; Koehn BH; Veenstra R; Taylor PA; Panoskaltsis-Mortari A; Serody JS; Munn DH; Tolar J; Ochoa AC; Blazar BR
    Blood; 2010 Dec; 116(25):5738-47. PubMed ID: 20807889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide.
    Yang F; Li Y; Wu T; Na N; Zhao Y; Li W; Han C; Zhang L; Lu J; Zhao Y
    J Mol Med (Berl); 2016 Aug; 94(8):911-20. PubMed ID: 26936474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.
    Koehn BH; Apostolova P; Haverkamp JM; Miller JS; McCullar V; Tolar J; Munn DH; Murphy WJ; Brickey WJ; Serody JS; Gabrilovich DI; Bronte V; Murray PJ; Ting JP; Zeiser R; Blazar BR
    Blood; 2015 Sep; 126(13):1621-8. PubMed ID: 26265697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity.
    Messmann JJ; Reisser T; Leithäuser F; Lutz MB; Debatin KM; Strauss G
    Blood; 2015 Aug; 126(9):1138-48. PubMed ID: 26185131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS converts Gr-1(+)CD115(+) myeloid-derived suppressor cells from M2 to M1 via P38 MAPK.
    Yang Y; Zhang R; Xia F; Zou T; Huang A; Xiong S; Zhang J
    Exp Cell Res; 2013 Jul; 319(12):1774-1783. PubMed ID: 23701951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.
    Kurkó J; Vida A; Ocskó T; Tryniszewska B; Rauch TA; Glant TT; Szekanecz Z; Mikecz K
    PLoS One; 2014; 9(11):e111815. PubMed ID: 25369029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.
    Yi H; Guo C; Yu X; Zuo D; Wang XY
    J Immunol; 2012 Nov; 189(9):4295-304. PubMed ID: 23034169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
    Fujimoto K; Uchida K; Yin E; Zhu J; Kojima Y; Uchiyama M; Yamamoto Y; Bashuda H; Matsumoto R; Tokushige K; Harada M; Inomata T; Kitaura J; Murakami A; Okumura K; Takeda K
    Transpl Immunol; 2021 Aug; 67():101405. PubMed ID: 33975012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.